The prevalence of multiple sclerosis in the Middle East

Neuroepidemiology
Jasem Al-HashelChristina Wolfson

Abstract

The prevalence of multiple sclerosis (MS) in the Middle East has been reported to be low to medium. To verify this assertion we conducted a review of published data on the occurrence of MS in the Middle East. Fourteen studies reporting on the prevalence of MS in the Middle East were initially identified, 5 of which were excluded due to inadequate data or serious methodological limitations. The data from the 9 included studies suggested that the prevalence of MS may vary widely within the Middle East, from low to high. However, these 9 studies were inconsistent in case ascertainment, inclusion criteria and methods of prevalence calculation, and most did not include age/sex standardization. Methodological inconsistencies among studies make it difficult to be confident in drawing conclusions about the prevalence of MS in the Middle East. Nevertheless, there is little evidence to support the assertion that the prevalence of MS in the Middle East is low to medium. Rather, the prevalence of MS in the Middle East may range from low to high, depending on the specific population and environment of study. However, to confirm these findings, further epidemiological research is needed.

Citations

Aug 28, 2014·The Journal of the Egyptian Public Health Association·Hisham S AbdelrahmanLobna I Sultan
Oct 12, 2011·The International Journal of Neuroscience·R AlroughaniS Lamdhade
Apr 6, 2011·The International Journal of Neuroscience·Jihad Inshasi, Mona Thakre
Aug 10, 2013·The International Journal of Neuroscience·Bassem YamoutMaurice Dahdaleh
Jun 22, 2012·Clinical Neurology and Neurosurgery·Ali MoghtaderiShahryar Shahraki-Ibrahimi
Jan 24, 2014·Multiple Sclerosis International·Mohammed AljumahAbdulkader Daif
Jan 1, 2013·Clinical Neurology and Neurosurgery·Naser SharafaddinzadehBita Shalbafan
Sep 21, 2016·Multiple Sclerosis and Related Disorders·Nicoline SchiessMiklos Szolics
Sep 13, 2013·Multiple Sclerosis : Clinical and Laboratory Research·R AlroughaniJ Al-Hashel
Jul 31, 2010·Multiple Sclerosis : Clinical and Laboratory Research·C AhlgrenO Andersen
Oct 22, 2015·The Cochrane Database of Systematic Reviews·Chunsong YangJin Wen
Jun 13, 2019·Arquivos de neuro-psiquiatria·Taysa Alexandrino Gonsalves Jubé RibeiroDenise Sisterolli Diniz
Jan 25, 2020·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Maya M Zeineddine, Bassem I Yamout
Sep 26, 2020·Therapeutic Advances in Neurological Disorders·Raed AlroughaniAly Ezzat
Mar 6, 2019·International Journal of MS Care·Nicoline SchiessTaoufik Alsaadi
Jun 20, 2018·BMC Neurology·Osama Al WutaydMohammed Al Jumah

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.